All the news Showing 10 of 20 articles from: Prognosis and disease progressionGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Progression to severe fibrosis or cirrhosis is common among baby boomers with hepatitis C in the US Liz Highleyman / 05 March 2015 The burden of hepatitis C virus (HCV) infection is high in the US, with a substantial number of individuals born between 1945 and 1965 having advanced fibrosis or cirrhosis and therefore being at ... Many hepatitis C patients with cirrhosis or advanced fibrosis face liver failure and liver cancer Liz Highleyman / 07 January 2015 Nearly one-third of chronic hepatitis C patients with liver cirrhosis and 12% with advanced fibrosis progressed to decompensation within five years, and 23% and 11%, respectively, died, according to a study presented ... Sustained virological response to hepatitis C treatment reduces mortality, liver cancer and liver transplants Liz Highleyman / 10 November 2014 People who achieve sustained virological response (SVR) when treated with interferon-based therapy for hepatitis C have a lower risk of death, are less likely to develop liver cancer and need fewer liver transplants ... Successful hepatitis C treatment reduces risk of liver cancer and death, but most remain untreated Liz Highleyman / 19 November 2013 Hepatitis C treatment that leads to viral cure significantly reduces the likelihood of liver disease progression and liver-related mortality, but most people with hepatitis C remain untreated, according to a presentation at The Liver ... Smoking cannabis does not accelerate progression of liver disease in people with HIV/HCV co-infection Michael Carter / 06 August 2013 Smoking cannabis does not worsen liver disease in people with HIV and hepatitis C virus (HCV) co-infection, Canadian research published in the online edition of Clinical Infectious Diseases shows. “We found no evidence that ... DDW 2013: Does Treating Herpes Help Suppress Hepatitis C Virus? HIVandhepatitis.com / 30 May 2013 EASL publishes first comprehensive literature review on the burden of liver disease in Europe Eurekalert Inf Dis / 22 February 2013 Decompensated liver disease more frequent in HIV/HCV co-infected people Liz Highleyman / 26 July 2012 Despite effective antiretroviral therapy, people co-infected with HIV and hepatitis C remain at higher risk for decompensated liver disease and other liver-related complications than those with hepatitis C alone, according to findings presented on ... Insulin resistance is a big risk factor for the progression of liver fibrosis in HIV/HCV co-infected people Michael Carter / 13 July 2012 Insulin resistance is associated with the progression of liver fibrosis in people co-infected with HIV and hepatitis C, Canadian researchers report in the online edition of AIDS. Earlier research has shown that ... Co-infection with hepatitis C increases mortality risk by 50% for patients with AIDS Michael Carter / 06 May 2012 Co-infection with hepatitis C increases the risk of death for patients with AIDS by 50%, according to the results of a large study published in the online edition of Clinical Infectious Diseases. ... ← Prev12Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive